Project Resurgence Communication Trial
Comparison of the Effectiveness of Communication Strategies on the Return to In-Person Visits to a Medical Center After the Emergence of COVID-19: A Randomized Trial
1 other identifier
interventional
11,120
1 country
1
Brief Summary
Randomized, double-blind, of standard of care vs additional communication and factorial design of intervention letter vs. control letter and EHR vs mail delivery mechanism in patients who canceled visits and did not reschedule over a 90 day period starting March 9, 2020.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2020
CompletedFirst Posted
Study publicly available on registry
June 5, 2020
CompletedStudy Start
First participant enrolled
June 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 17, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 17, 2020
CompletedResults Posted
Study results publicly available
October 28, 2021
CompletedOctober 28, 2021
October 1, 2021
1 month
May 29, 2020
October 25, 2021
October 26, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Percent of Participants With Visit or Procedure With Provider
1 month
Secondary Outcomes (2)
Percent of Participants With Scheduled Visit or Procedure With Provider
1 month
Percent of Participants With Completed Telemedicine Visit With Provider
1 month
Study Arms (5)
No intervention
NO INTERVENTIONMPM control letter
ACTIVE COMPARATORMPM intervention letter
EXPERIMENTALMailed control letter
ACTIVE COMPARATORMailed intervention letter
EXPERIMENTALInterventions
Control letter vs. intervention letter
Eligibility Criteria
You may qualify if:
- Patients with a cancellation or failure to show for a procedure or visit from March 9, 2020 through June 7, 2020 (90 days) and who have not rescheduled as of the date of randomization
You may not qualify if:
- Death
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Related Publications (1)
Cappola AR, Schriver ER, Mowery DL, Wollack C, Ives CT, Gonzales R, Cappella JN. Effect of Targeted Messaging on Return to In-Person Visits During the COVID-19 Pandemic: A Randomized Clinical Trial. JAMA Netw Open. 2021 Jun 1;4(6):e2115211. doi: 10.1001/jamanetworkopen.2021.15211.
PMID: 34190999DERIVED
Results Point of Contact
- Title
- Dr. Anne Cappola
- Organization
- University of Pennsylvania
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 29, 2020
First Posted
June 5, 2020
Study Start
June 15, 2020
Primary Completion
July 17, 2020
Study Completion
July 17, 2020
Last Updated
October 28, 2021
Results First Posted
October 28, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share